Anebulo Pharmaceuticals Inc (ANEB) Live Share Price, Invest From India

Anebulo Pharmaceuticals Inc Stock Performance

as on May 7, 2026 at 6:05 am IST

Day's High
$0.46
Day's Price Range
$0.55
$0.46
19.57%
Upside
52 Week's Low
52 Week's High
$0.30
52-Week Price Range
$3.42
$0.46
34.80%
Downside
643.48%
Upside

Anebulo Pharmaceuticals Inc share price movements today

Previous Close: $0.46
Open: $0.50
Volume: 36.0K
Day's Low - High: $0.46 - $0.55
52 Week Low - High: $0.30 - $3.42

Anebulo Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Anebulo Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Anebulo Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.8M

EPS (TTM)

-0.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-69.69%

Anebulo Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anebulo Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Anebulo Pharmaceuticals Inc	BUY	$18.8M	NA	NA	0.00%
Vertex Pharmaceuticals Inc	BUY	$108.5B	98.9%	25.38	35.51%
Alnylam Pharmaceuticals Inc	BUY	$40.5B	130.77%	76.32	12.55%
BeiGene, Ltd.	NA	$32.5B	NA	70.89	5.37%
Regeneron Pharmaceuticals Inc	BUY	$75.6B	45.15%	17.6	29.65%

Analyst Recommendation on Anebulo Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Anebulo Pharmaceuticals Inc. Average target price of $3

Anebulo Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Anebulo Pharmaceuticals Inc.

What analysts predicted

84.67%UPSIDE

Target Price

Current Price

$0.46

Analyzed by

9 Analysts

Target

$3.00

Anebulo Pharmaceuticals Inc target price $3, a slight upside of 84.67% compared to current price of $0.46. According to 9 analysts rating.

Anebulo Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-2	-1	-1	-2	-2	-1	-2	-2	-2
EBITDA	0	-2	-1	-1	-1	-2	-1	-2	-2	-2
Interest Expense	-	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-1	-1	-2	-2	-1	-2	-2	-1
Income Tax Expense	0	0	-1	0	-	-2	-	-	-	-
Net Income	-2	-2	-1	-1	-2	-2	-1	-2	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anebulo Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Jun 2024	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	-	-3	-	-6	-	-11	-	-8	-9
EBITDA	-	-30	-	-6	-	-11	-	-7	-8
Interest Expense	-	0	-	0	-	-	-	0	0
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-30	-	-6	-	-11	-	-8	-8
Income Tax Expense	-	0	-	0	-	0	-	-	-
Net Income	-30	-30	-30	-6	-6	-11	-11	-8	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Anebulo Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-1	-1	-2	-2	-1	-2	-2	-1
Operating Cash Flow	-1	-1	-2	-1	-1	-1	-1	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	-	-	-	15	0	-	-	-
Change in Cash	-1	-1	-2	-1	13	-1	-1	-1	-1

Anebulo Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-30	-6	-11	-8	-8
Operating Cash Flow	-4	-5	-9	-8	-6
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	21	6	6	0	14
Change in Cash	16	-5	-3	-8	8

Global Institutional Holdings in Anebulo Pharmaceuticals Inc

Funds	Holdings
UBS Group AG	0%
Vanguard Group Inc	1.07%
Geode Capital Management, LLC	0.43%
Millennium Management LLC	0.37%
JPMorgan Chase & Co	0.01%

See all

Insights on Anebulo Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 144.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.8% return, outperforming this stock by 92.4%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ANEB stock has moved down by -54.3%

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.

Organisation	Anebulo Pharmaceuticals Inc
Headquarters	1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
Industry	Biotechnology
CEO	Mr. Richard Anthony Cunningham
E-voting on shares	Click here to vote

Key Management of Anebulo Pharmaceuticals Inc

Name	Title
Mr. Richard Anthony Cunningham	CEO & Director
Mr. Daniel V. George	Acting CFO & Secretary
Dr. Kenneth C. Cundy Ph.D.	Chief Scientific Officer
Dr. Joseph F. Lawler M.D., Ph.D.	Founder & Chairman

FAQs

What is Anebulo Pharmaceuticals Inc share price today?

Anebulo Pharmaceuticals Inc share price today is $0.46 as on May 7, 2026 at 12:35 am IST at the close of the market. Anebulo Pharmaceuticals Inc share today touched a day high of $0.55 and a low of $0.46.

What is the 52 week high and 52 week low for Anebulo Pharmaceuticals Inc share?

Anebulo Pharmaceuticals Inc share touched a 52 week high of $3.42 on July 23, 2025 and a 52 week low of $0.3 on March 3, 2026. Anebulo Pharmaceuticals Inc stock price today i.e. May 7, 2026 at 12:35 am IST is closed at $0.46,which is 86.55% down from its 52 week high and 53.38% up from its 52 week low.

What is Anebulo Pharmaceuticals Inc's market capitalisation today?

Anebulo Pharmaceuticals Inc market capitalisation is $0.00T as on May 7, 2026 at 12:35 am IST.

How to invest in Anebulo Pharmaceuticals Inc Stock (ANEB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Anebulo Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anebulo Pharmaceuticals Inc Shares that will get you 3.2609 shares as per Anebulo Pharmaceuticals Inc share price of $0.46 per share as on May 7, 2026 at 12:35 am IST.

What is the minimum amount required to buy Anebulo Pharmaceuticals Inc Stock (ANEB) from India?

Indian investors can start investing in Anebulo Pharmaceuticals Inc (ANEB) shares with as little as ₹94.61 or $1 (as of May 7, 2026 at 6:11 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Anebulo Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 6:11 pm IST). Based on Anebulo Pharmaceuticals Inc share’s latest price of $0.46 as on May 7, 2026 at 12:35 am IST, you will get 21.7391 shares of Anebulo Pharmaceuticals Inc. Learn more about fractional shares .